Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)

May 10, 2022 updated by: Seung Hwan Lee, Wonju Severance Christian Hospital
The left distal radial approach (DRA) has been introduced as a feasible and safe alternative route of the radial artery. However, there is still lack of evidence for DRA regarding the feasibility, safety, effective time for hemostasis and hemostasis method. This prospective multicenter registry aimed to investigate the safety and efficacy of DRA for CAG and PCI.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Based on the results that radial approach (RA) reduced mortality and bleeding complications compared with femoral approach (FA), RA has become the standard of care for coronary angiography (CAG) and percutaneous coronary intervention (PCI). RA provides better comfortability for the patients and immediate mobilization after CAG or PCI. Therefore, 2018 ESC/EACTS guidelines recommend RA as the standard approach, unless there are overriding procedural considerations.

Operators usually prefer right RA because most of the operators are right-handed and right hand of the patient is closer to the operator. In contrast, longer distance to the left radial artery cause neck or back sprain of the operators, especially when the height of the operator is short, or the patient is obese. Nevertheless, left RA might be easier to manipulate catheter because of less tortuosity compared to the right RA and similar approach curvature with FA. Left RA also gives a chance to the right-handed patients to use their right hand freely.

Recently, the left distal radial approach (DRA) has been introduced as a feasible and safe alternative route of the radial artery. The left hand in the prone position is placed either on the left groin or beside the left hip according to operator preference. The operator punctures the distal radial artery around the anatomical snuffbox. After the first report for the feasibility and safety of left DRA in 70 patients, Lee et al. demonstrated that the success rates of arterial puncture, CAG and PCI were 95.5% (191/200), 100% (187/187), and 98.9% (86/87), respectively. The complication rates were only 7.9% including 14 (7.4%) minor hematomas and one (0.5%) arterial dissection. No serious complications were occurred such as distal radial artery occlusion, perforation, pseudoaneurysm, or arteriovenous fistula. Several studies for DRA also showed similar favorable results regarding procedural success and bleeding complications.

Radial arterial occlusion after RA remains an unsolved problem. According to the Leipzig prospective vascular ultrasound registry, the occlusion rate of radial artery was 14.4% in case of 5Fr sheath and 33.1% in 6Fr sheath, respectively. In this point of view, DRA could be a promising solution to lower the incidence rate of arterial occlusion. Moreover, DRA can have a potential benefit in patients requiring arteriovenous fistula and in patients who need the radial artery as a conduit for coronary artery bypass graft because of the absence of radial injury.

There is still lack of evidence for DRA regarding the feasibility, safety, effective time for hemostasis and hemostasis method. Unknown complications related to DRA also should be addressed. Therefore, this prospective multicenter registry aimed to investigate the safety and efficacy of DRA for CAG and PCI.

Study Type

Observational

Enrollment (Actual)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Busan, Korea, Republic of
        • Inje University Busan Paik Hospital
      • Busan, Korea, Republic of
        • Inje University Haeundae Paik Hospital
      • Busan, Korea, Republic of
        • Pusan National University Hospital
      • Busan, Korea, Republic of
        • Kosin Univeristy Gospel Hospital
      • Cheongju, Korea, Republic of
        • Chungbuk National University Hospital
      • Chuncheon, Korea, Republic of
        • Kangwon National University Hospital
      • Daegu, Korea, Republic of
        • Daegu Catholic University Medical Center
      • Gangneung, Korea, Republic of
        • GangNeung Asan Hospital
      • Goyang, Korea, Republic of
        • Inje University Ilsan Paik Hospital
      • Gyeongju, Korea, Republic of
        • Dongguk University Gyeongju Hospital
      • Incheon, Korea, Republic of
        • Uvis Hospital
      • Uijeongbu, Korea, Republic of
        • The Catholic University of Korea Uijeongbu St. Mary's Hospital
      • Wonju, Korea, Republic of
        • Wonju Severance Christian Hospital
    • Kyeonggi-do
      • Yongin-si, Kyeonggi-do, Korea, Republic of, 17046
        • Yongin Severance Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who need coronary angiography will be enrolled.

Description

Inclusion Criteria:

  • Patients aged ≥ 20 years who planned coronary angiography
  • Patients with palpable distal radial artery
  • Patients who give informed consent

Exclusion Criteria:

  • Patients with small or non-palpable distal radial artery
  • Positive result in modified Allen test (suspicious of single blood supply)
  • Pregnant women, possible candidate for pregnancy, or breastfeeding women
  • Patients who are deemed unsuitable by the investigator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rate of coronary angiography
Time Frame: Through procedure completion, up to 6 hours
Success rate of coronary angiography (%)
Through procedure completion, up to 6 hours
Success rate of percutaneous coronary intervention
Time Frame: Through procedure completion, up to 6 hours
Success rate of percutaneous coronary intervention (%)
Through procedure completion, up to 6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rate of distal radial artery puncture
Time Frame: Through procedure completion, up to 6 hours
Success rate of distal radial artery puncture (%)
Through procedure completion, up to 6 hours
Puncture time
Time Frame: Through procedure completion, up to 6 hours
Puncture time (minute)
Through procedure completion, up to 6 hours
Hemostasis time
Time Frame: Through procedure completion, up to 24 hours
Hemostasis time (minute)
Through procedure completion, up to 24 hours
Puncture-related complications
Time Frame: Up to 1 month
Puncture-related complications (%)
Up to 1 month
Total procedure time
Time Frame: Through procedure completion, up to 6 hours
Total procedure time (minutes)
Through procedure completion, up to 6 hours
Total fluoroscopic time
Time Frame: Through procedure completion, up to 6 hours
Total fluoroscopic time (minute)
Through procedure completion, up to 6 hours
Total fluoroscopic dose
Time Frame: Through procedure completion, up to 6 hours
Total fluoroscopic dose (Gray/cm2)
Through procedure completion, up to 6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Seung-Hwan Lee, MD, PhD, Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 9, 2019

Primary Completion (ACTUAL)

October 30, 2021

Study Completion (ACTUAL)

January 23, 2022

Study Registration Dates

First Submitted

August 31, 2019

First Submitted That Met QC Criteria

September 5, 2019

First Posted (ACTUAL)

September 6, 2019

Study Record Updates

Last Update Posted (ACTUAL)

May 11, 2022

Last Update Submitted That Met QC Criteria

May 10, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Distal radial approach

Subscribe